1. Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
   Huaxin Zhu et al, 2022, Frontiers in Oncology CrossRef
2. Anti-silencing function 1B knockdown suppresses the malignant phenotype of colorectal cancer by inactivating the phosphatidylinositol 3-kinase/AKT pathway
   Gen-Hua Yu et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
3. ARRDC4 and UBXN1: Novel Target Genes Correlated with Prostate Cancer Gleason Score
   Jong Jin Oh et al, 2021, Cancers CrossRef
4. Protumor Effects of Histone H3–H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and In Vitro Analyses
   Liyang Wu et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
5. Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer
   Yang Liu et al, 2023, Aging CrossRef
6. Advances in Targeting Cancer-Associated Genes by Designed siRNA in Prostate Cancer
   Amirhossein Bahreyni et al, 2020, Cancers CrossRef
7. ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
   Weigang Qiu et al, 2022, Frontiers in Oncology CrossRef
8. Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
   Xianmo Wang et al, 2022, Frontiers in Oncology CrossRef
9. Distinct role of histone chaperone Asf1a and Asf1b during fertilization and pre-implantation embryonic development in mice
   Xuemei Wang et al, 2021, Epigenetics & Chromatin CrossRef
10. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
    Xiaoxi Ouyang et al, 2022, Frontiers in Oncology CrossRef
11. Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA
    Liya Huang et al, 2022, Frontiers in Genetics CrossRef
12. ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types
    Wencheng Zhang et al, 2021, Frontiers in Oncology CrossRef
13. ASF1B, as an Independent Prognostic Biomarker, Correlates with Immune Infiltrates in Hepatocellular Carcinoma
    Renzhi Li et al, 2023, Combinatorial Chemistry & High Throughput Screening CrossRef
14. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
    Shirong Zhang et al, 2022, Frontiers in Genetics CrossRef
15. Construction of Novel lncRNA–miRNA–mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma
    Tian Zhan et al, 2021, Frontiers in Oncology CrossRef